Spero Therapeutics, Inc. (SPRO)
1.13
+0.01
(+0.89%)
USD |
NASDAQ |
Sep 11, 16:00
1.14
+0.01
(+0.88%)
After-Hours: 20:00
Spero Therapeutics Price : 1.13 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 1.13 | 1.15 | 1.13 | 1.13 | 310631.0 |
| Sep 10, 2026 | 1.18 | 1.18 | 1.12 | 1.12 | 569285.0 |
| Sep 09, 2026 | 1.20 | 1.21 | 1.17 | 1.17 | 367061.0 |
| Sep 08, 2026 | 1.21 | 1.22 | 1.19 | 1.19 | 348592.0 |
| Sep 04, 2026 | 1.20 | 1.22 | 1.185 | 1.21 | 362984.0 |
| Sep 03, 2026 | 1.22 | 1.23 | 1.201 | 1.22 | 203326.0 |
| Sep 02, 2026 | 1.20 | 1.239 | 1.20 | 1.22 | 169514.0 |
| Sep 01, 2026 | 1.22 | 1.22 | 1.18 | 1.20 | 385398.0 |
| Aug 31, 2026 | 1.20 | 1.23 | 1.20 | 1.22 | 338466.0 |
| Aug 28, 2026 | 1.21 | 1.22 | 1.181 | 1.20 | 312829.0 |
| Aug 27, 2026 | 1.22 | 1.23 | 1.18 | 1.21 | 538487.0 |
| Aug 26, 2026 | 1.22 | 1.228 | 1.20 | 1.22 | 154763.0 |
| Aug 25, 2026 | 1.23 | 1.26 | 1.20 | 1.23 | 645540.0 |
| Aug 24, 2026 | 1.22 | 1.24 | 1.20 | 1.215 | 367273.0 |
| Aug 21, 2026 | 1.22 | 1.246 | 1.21 | 1.22 | 359141.0 |
| Aug 20, 2026 | 1.22 | 1.27 | 1.20 | 1.21 | 558771.0 |
| Aug 19, 2026 | 1.20 | 1.24 | 1.192 | 1.23 | 480182.0 |
| Aug 18, 2026 | 1.20 | 1.20 | 1.175 | 1.20 | 477408.0 |
| Aug 17, 2026 | 1.21 | 1.24 | 1.19 | 1.19 | 299013.0 |
| Aug 14, 2026 | 1.26 | 1.26 | 1.194 | 1.23 | 744546.0 |
| Aug 13, 2026 | 1.26 | 1.30 | 1.21 | 1.24 | 1.293M |
| Aug 12, 2026 | 1.24 | 1.245 | 1.185 | 1.19 | 774554.0 |
| Aug 11, 2026 | 1.24 | 1.25 | 1.21 | 1.23 | 364060.0 |
| Aug 10, 2026 | 1.25 | 1.276 | 1.225 | 1.23 | 351020.0 |
| Aug 07, 2026 | 1.27 | 1.280 | 1.24 | 1.26 | 459026.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Inovio Pharmaceuticals, Inc. | 1.25 |
| Fortress Biotech, Inc. | 2.52 |
| Kura Oncology, Inc. | 11.39 |
| Legend Biotech Corp. | 18.64 |
| ACADIA Pharmaceuticals, Inc. | 27.83 |
Price Related Metrics
| PE Ratio | 10.36 |
| PS Ratio | 1.518 |
| Price to Book Value | 1.486 |
| Price to Free Cash Flow | 3.331 |
| Earnings Yield | 9.65% |
| Market Cap | 65.71M |
| Operating PE Ratio | 25.29 |
| Normalized PE Ratio | 9.700 |